Clinical Trial

Bacteriophage Cocktail Therapy for Multidrug-Resistant Gram-Negative Ventilator-Associated Pneumonia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to systematically evaluate the efficacy and safety of bacteriophage cocktail therapy in patients with ventilator-associated pneumonia caused by Gram-negative bacterial infections.
Trial Details
NCT Number NCT07202234
Lead Sponsor Chinese PLA General Hospital
Collaborators: Peking University Third Hospital, Zhengzhou Central Hospital, Henan Provincial People's Hospital, The First Affiliated Hospital of Zhengzhou University, Chinese the Eighth Medical Center of the General Hospital of the People's Liberation Army, The First Medical Center of Chinese PLA General Hospital
Conditions VAP - Ventilator Associated Pneumonia
Enrollment 248 participants
Start Date 2025-11-01
Primary Completion 2028-05-31 (estimated)
Study Completion 2028-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-01